|
|
||||||||
Biology of Reproduction, Vol 22, 289-296, Copyright © 1980 by Society for the Study of Reproduction
1 The Rockefeller University,
New York, New York 10021 The possible role of cyclic AMP (cAMP), prostaglandin E2, progesterone and estradiol-17
2 The Population Council,
The Rockefeller University,
New York, New York 10021
in
in vitro induction of the rat cumulus oophorus mucification was studied with the scanning electron
microscope. Follicular cumulus-oocyte complexes were isolated at early proestrus and cultured for
24 h. Cyclic AMP levels in the incubated complexes were elevated by addition of cAMP derivatives
(dibutyryl cAMP or 8 bromo cAMP), the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine
(MIX), or the adenylate cyclase stimulator, cholera enterotoxin. Under all these culture conditions
the cumulus cells were stimulated to secrete a hyaluronidase-sensitive mucoid material which
coated the cumulus-oocyte complexes. These complexes were similar in appearance to those
incubated in the presence of gonadotropins. In the absence of the above agents extracellular
material was not observed. In vitro cumulus mucification was not induced by prostaglandin E2;
indomethacin, an inhibitor of prostaglandin synthetase, failed to block mucification in complexes
that have been incubated in the presence of LH. Cumulus complexes were not stimulated to
mucify in vitro by progesterone or estradiol-17
. Therefore, the response of the cumulus cells to
the gonadotropic stimulus appears to be mediated by cAMP. Prostaglandin E2 and steroids seem
not to be involved in this process.
Accepted on October 17, 1979
This article has been cited by other articles:
![]() |
M. D. Calder, A. N. Caveney, M. E. Westhusin, and A. J. Watson Cyclooxygenase-2 and Prostaglandin E2(PGE2) Receptor Messenger RNAs Are Affected by Bovine Oocyte Maturation Time and Cumulus-Oocyte Complex Quality, and PGE2 Induces Moderate Expansion of the Bovine Cumulus In Vitro Biol Reprod, July 1, 2001; 65(1): 135 - 140. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |